Target intelligence / Profile preview

POTE ankyrin domain family member I, pseudogene (POTENP (or ACTG1P24, as alternately described in some records))

Target
POTENP (or ACTG1P24, as alternately described in some records)
Molecular classification
Other (pseudogene; member of POTE ankyrin domain family)
01

Overview

POTE ankyrin domain family member I, pseudogene (commonly referred to as POTENP, ACTG1P24, or POTE ankyrin domain family, member I, pseudogene) is classified as a pseudogene and a presumed non-coding locus within the human genome. It belongs to the primate-specific POTE ankyrin domain family, whose members are characteristically expressed in reproductive tissues such as prostate, ovary, testis, and placenta[3]. As a pseudogene, ACTG1P24 is not believed to encode a functional protein, nor is it implicated as a therapeutic target, receptor, enzyme, transporter, or transcription factor. Its significance appears limited to evolutionary biology and genomic studies rather than drug discovery or biomarker development[6][2]. Additional Notes: - The term ACTG1P24 does not correspond to a conventional, functional protein target but refers to an annotated non-functional genetic element. - There is some confusion in the literature due to the overlap in gene family names and similar pseudogene designations, which makes this entry not suitable for drug targeting or clinical relevance. - If a true functional gene or therapeutic target was expected by the query, this record should be flagged as "incorrect" for bioactivity-targeting purposes[6][2].

Other names
ACTG1P24POTENPPOTE ankyrin domain family, member I, pseudogenePOTE ankyrin domain family, member N, pseudogenePOTE ankyrin domain family member I, pseudogene
02

Mechanism of action

None

03

Biological functions

None established; pseudogene with no demonstrated functional protein product
04

Disease associations

Other (no clear evidence of disease association; no therapeutic or pathological role established)

Beyond the preview

Go deeper on POTE ankyrin domain family member I, pseudogene (POTENP (or ACTG1P24, as alternately described in some records)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on POTE ankyrin domain family member I, pseudogene (POTENP (or ACTG1P24, as alternately described in some records)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call